Market Cap 52.27B
Revenue (ttm) 20.18B
Net Income (ttm) 1.71B
EPS (ttm) N/A
PE Ratio 12.94
Forward PE 12.87
Profit Margin 8.45%
Debt to Equity Ratio 0.70
Volume 4,688,900
Avg Vol 2,779,930
Day's Range N/A - N/A
Shares Out 286.61M
Stochastic %K 28%
Beta 0.25
Analysts Sell
Price Target $213.71

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-fre...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 847 6800
Website: www.bd.com
Address:
1 Becton Drive, Franklin Lakes, United States
11thestate
11thestate Jul. 31 at 6:05 AM
$BDX agreed to settle $85 million to resolve claims that it misled investors about the functionality and safety of its Alaris infusion pumps, leading to a significant stock price drop. Who’s eligible? Anyone who bought and held $BDX stock between November 5, 2019, and February 5, 2020. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is $2.14 — but if only ~25% of eligible investors file, the effective payout could increase to $8.56 per share. Can I still file? Yes — late claims are being considered, pending court approval. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/bdx-shareholder-settlement
0 · Reply
TalkMarkets
TalkMarkets Jul. 22 at 5:36 PM
3 #Dividend Growth Stocks For Long-Term Compounding $AFL $BDX $SHW https://talkmarkets.com/content/stocks--equities/3-dividend-growth-stocks-for-long-term-compounding?post=510760
0 · Reply
11thestate
11thestate Jul. 19 at 12:19 AM
$BDX investors — there’s a potential path to recover losses. It’s worth a look: https://11th.com/cases/bdx-shareholder-settlement #BectonDickinson #BDX
0 · Reply
inelegantinvest
inelegantinvest Jul. 16 at 4:02 PM
Becton Dickinosn Announces Planned Spinoff of Biosciences & Diagnostics — Waters Deal via $17.5 B Reverse Morris Trust https://www.stockspinoffs.com/2025/07/16/becton-dickinosn-announces-planned-spinoff-of-biosciences-diagnostics-waters-deal-via-17-5-b-reverse-morris-trust/ $BDX $WAT
0 · Reply
InItToWinIt100
InItToWinIt100 Jul. 16 at 1:14 PM
$BDX $WAT https://www.wsj.com/business/deals/waters-corp-deal-for-becton-dickinson-unit-a-long-term-play-with-some-risks-b8c095f5?mod=deals_news_article_pos2
0 · Reply
TalkMarkets
TalkMarkets Jul. 15 at 7:23 PM
BDX: After 53 Years of Dividend Growth – Is This Stock Finally Worth Buying? $BDX https://talkmarkets.com/content/stocks--equities/bdx-after-53-years-of-dividend-growth--is-this-stock-finally-worth-buying?post=509442&userid=166882
0 · Reply
ZacksResearch
ZacksResearch Jul. 15 at 1:37 PM
$BDX teams up with $WAT — a game-changer for diagnostics? 🤔 🚀 A $17.5B implied value Reverse Morris Trust transaction set to tap into a $40B market 💪 Projected to hit $9B revenue & $3.3B EBITDA by 2030 🔍 BD shareholders to get a 39.2% stake in the new entity Strategic insights here 👉 https://www.zacks.com/stock/news/2582321/bd-partners-with-waters-to-build-high-volume-diagnostics-leader?cid=sm-stocktwits-2-2582321-body-1783&ADID=SYND_STOCKTWITS_TWEET_2_2582321_BODY_1783
0 · Reply
ZacksResearch
ZacksResearch Jul. 15 at 12:17 PM
$BDX just teamed up with Waters in a $17.5B move — here’s why it matters 🧪💰 The two are building a high-volume diagnostics leader with eyes on $9B in revenue by 2030. Big ambitions, big money. See what’s behind the bold target 👉 https://www.zacks.com/stock/news/2582321/bd-partners-with-waters-to-build-high-volume-diagnostics-leader?cid=sm-stocktwits-2-2582321-teaser-1712&ADID=SYND_STOCKTWITS_TWEET_2_2582321_TEASER_1712
0 · Reply
TheDayTradingAcademy
TheDayTradingAcademy Jul. 15 at 10:53 AM
The U.S. life sciences tools maker $WAT shares fell -13.81% on Monday at $304.18, after announcing plans to merge with Becton Dickinson’s Biosciences & Diagnostic Solutions unit. Waters will take on $4 billion in debt & issue + 39.2% of its stock to Becton Dickinson shareholders, under the terms of the deal. Becton shareholders will also receive a $4B payout. $BDX shares added +0.64% at $177.09. Waters stock is down -10.82% in the past month, -18.01% in 2025 & -3.96% y/y, with a market cap of $18.1B.
0 · Reply
Vandenberg23
Vandenberg23 Jul. 14 at 5:56 PM
$BDX I’m still not understanding…what did BD spin off? What is in the Biosciences and Diagnostics group? What are they keeping? Or are they now one big happy BD-Waters?
1 · Reply
Latest News on BDX
Best Dividend Aristocrats For August 2025

Jul 28, 2025, 5:19 AM EDT - 4 days ago

Best Dividend Aristocrats For August 2025

ABT BEN


22 Dividend Kings At Discounted Valuations

Jul 27, 2025, 12:14 PM EDT - 5 days ago

22 Dividend Kings At Discounted Valuations

ABM ADM AMZN AWR BKH CWT FRT


20 Kiplinger July Dividend Favorites: No Cigars

Jul 27, 2025, 11:45 AM EDT - 5 days ago

20 Kiplinger July Dividend Favorites: No Cigars

APD DUK EPD GS HD JNJ KVUE


BD Board Declares Dividend

Jul 22, 2025, 4:15 PM EDT - 10 days ago

BD Board Declares Dividend


Best Dividend Kings: July 2025

Jul 22, 2025, 9:31 AM EDT - 10 days ago

Best Dividend Kings: July 2025

ABBV ABM ABT ADM ADP AWR BKH


Best Dividend Aristocrats For July 2025

Jun 29, 2025, 7:19 AM EDT - 4 weeks ago

Best Dividend Aristocrats For July 2025

ABBV ABT ADM ADP AFL ALB AMCR


New vaccine panel meeting underway

Jun 26, 2025, 11:46 AM EDT - 5 weeks ago

New vaccine panel meeting underway

BMY MRK UNH ZBH


Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now

Jun 25, 2025, 8:33 AM EDT - 5 weeks ago

Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now


Best Dividend Kings: June 2025

Jun 24, 2025, 8:49 AM EDT - 5 weeks ago

Best Dividend Kings: June 2025

ABT ADM BKH ED EMR FTS FUL


Best Dividend Aristocrats For June 2025

May 27, 2025, 10:15 PM EDT - 2 months ago

Best Dividend Aristocrats For June 2025

ABBV ABT ADM ADP AFL ALB AMCR


35 Barron's Pro-Picks: One Ideal May DiviDog

May 18, 2025, 4:51 AM EDT - 2 months ago

35 Barron's Pro-Picks: One Ideal May DiviDog

AGNC ASIX AZN CRM EPD FLMI FOX


The Best Health Care Stocks to Buy

May 8, 2025, 10:46 AM EDT - 3 months ago

The Best Health Care Stocks to Buy

CI SEM


Buy 3 "Safer" Dividend Kings Of 25 From May's 55

May 6, 2025, 12:58 PM EDT - 3 months ago

Buy 3 "Safer" Dividend Kings Of 25 From May's 55

ADM ADP BKH CWT ED FRT FTS


Stock Of The Day – Bullish Capitulation In Becton, Dickinson?

May 2, 2025, 9:54 AM EDT - 3 months ago

Stock Of The Day – Bullish Capitulation In Becton, Dickinson?


Cramer's Stop Trading: Becton Dickinson

May 1, 2025, 10:22 AM EDT - 3 months ago

Cramer's Stop Trading: Becton Dickinson


BD Reports Second Quarter Fiscal 2025 Financial Results

May 1, 2025, 6:30 AM EDT - 3 months ago

BD Reports Second Quarter Fiscal 2025 Financial Results


Best Dividend Aristocrats For May 2025

Apr 29, 2025, 8:07 PM EDT - 3 months ago

Best Dividend Aristocrats For May 2025

ABBV ABT ADM ADP AFL ALB AMCR


Becton, Dickinson and Company: It's Wait And See For Me

Apr 27, 2025, 1:17 AM EDT - 3 months ago

Becton, Dickinson and Company: It's Wait And See For Me


DGI For The DIY: 2024 Dividend Portfolio Review

Apr 17, 2025, 9:33 PM EDT - 3 months ago

DGI For The DIY: 2024 Dividend Portfolio Review

INTU MPWR


Best Dividend Aristocrats For April 2025

Mar 31, 2025, 4:07 PM EDT - 4 months ago

Best Dividend Aristocrats For April 2025

ABBV ABT ADM BEN BRO CAH CL


BD Named One of America's Most Innovative Companies by Fortune

Mar 31, 2025, 6:50 AM EDT - 4 months ago

BD Named One of America's Most Innovative Companies by Fortune


11thestate
11thestate Jul. 31 at 6:05 AM
$BDX agreed to settle $85 million to resolve claims that it misled investors about the functionality and safety of its Alaris infusion pumps, leading to a significant stock price drop. Who’s eligible? Anyone who bought and held $BDX stock between November 5, 2019, and February 5, 2020. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is $2.14 — but if only ~25% of eligible investors file, the effective payout could increase to $8.56 per share. Can I still file? Yes — late claims are being considered, pending court approval. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/bdx-shareholder-settlement
0 · Reply
TalkMarkets
TalkMarkets Jul. 22 at 5:36 PM
3 #Dividend Growth Stocks For Long-Term Compounding $AFL $BDX $SHW https://talkmarkets.com/content/stocks--equities/3-dividend-growth-stocks-for-long-term-compounding?post=510760
0 · Reply
11thestate
11thestate Jul. 19 at 12:19 AM
$BDX investors — there’s a potential path to recover losses. It’s worth a look: https://11th.com/cases/bdx-shareholder-settlement #BectonDickinson #BDX
0 · Reply
inelegantinvest
inelegantinvest Jul. 16 at 4:02 PM
Becton Dickinosn Announces Planned Spinoff of Biosciences & Diagnostics — Waters Deal via $17.5 B Reverse Morris Trust https://www.stockspinoffs.com/2025/07/16/becton-dickinosn-announces-planned-spinoff-of-biosciences-diagnostics-waters-deal-via-17-5-b-reverse-morris-trust/ $BDX $WAT
0 · Reply
InItToWinIt100
InItToWinIt100 Jul. 16 at 1:14 PM
$BDX $WAT https://www.wsj.com/business/deals/waters-corp-deal-for-becton-dickinson-unit-a-long-term-play-with-some-risks-b8c095f5?mod=deals_news_article_pos2
0 · Reply
TalkMarkets
TalkMarkets Jul. 15 at 7:23 PM
BDX: After 53 Years of Dividend Growth – Is This Stock Finally Worth Buying? $BDX https://talkmarkets.com/content/stocks--equities/bdx-after-53-years-of-dividend-growth--is-this-stock-finally-worth-buying?post=509442&userid=166882
0 · Reply
ZacksResearch
ZacksResearch Jul. 15 at 1:37 PM
$BDX teams up with $WAT — a game-changer for diagnostics? 🤔 🚀 A $17.5B implied value Reverse Morris Trust transaction set to tap into a $40B market 💪 Projected to hit $9B revenue & $3.3B EBITDA by 2030 🔍 BD shareholders to get a 39.2% stake in the new entity Strategic insights here 👉 https://www.zacks.com/stock/news/2582321/bd-partners-with-waters-to-build-high-volume-diagnostics-leader?cid=sm-stocktwits-2-2582321-body-1783&ADID=SYND_STOCKTWITS_TWEET_2_2582321_BODY_1783
0 · Reply
ZacksResearch
ZacksResearch Jul. 15 at 12:17 PM
$BDX just teamed up with Waters in a $17.5B move — here’s why it matters 🧪💰 The two are building a high-volume diagnostics leader with eyes on $9B in revenue by 2030. Big ambitions, big money. See what’s behind the bold target 👉 https://www.zacks.com/stock/news/2582321/bd-partners-with-waters-to-build-high-volume-diagnostics-leader?cid=sm-stocktwits-2-2582321-teaser-1712&ADID=SYND_STOCKTWITS_TWEET_2_2582321_TEASER_1712
0 · Reply
TheDayTradingAcademy
TheDayTradingAcademy Jul. 15 at 10:53 AM
The U.S. life sciences tools maker $WAT shares fell -13.81% on Monday at $304.18, after announcing plans to merge with Becton Dickinson’s Biosciences & Diagnostic Solutions unit. Waters will take on $4 billion in debt & issue + 39.2% of its stock to Becton Dickinson shareholders, under the terms of the deal. Becton shareholders will also receive a $4B payout. $BDX shares added +0.64% at $177.09. Waters stock is down -10.82% in the past month, -18.01% in 2025 & -3.96% y/y, with a market cap of $18.1B.
0 · Reply
Vandenberg23
Vandenberg23 Jul. 14 at 5:56 PM
$BDX I’m still not understanding…what did BD spin off? What is in the Biosciences and Diagnostics group? What are they keeping? Or are they now one big happy BD-Waters?
1 · Reply
schaeffers
schaeffers Jul. 14 at 5:21 PM
WORST SPX STOCK TODAY: $WAT (-11.1%) Today's tumble comes after $WAT agreed to merge with rival $BDX biosciences and diagnostic solutions unit for $17.5 billion. WAT is pacing for its worst day since April 2019, and is down 15% so far this year.
0 · Reply
11thestate
11thestate Jul. 11 at 12:42 AM
For all $BDX investors — you might be surprised, but we have good news. There’s actually a way to recover your losses. You won’t want to miss it. Go check it out now. #BectonDickinson #BDX ➡️ https://11th.com/cases/bdx-shareholder-settlement
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jul. 9 at 9:14 PM
$QNCCF $BDX $TSM This person is a master spammer Blocked
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 7 at 3:56 PM
$BDX Brilliant piece that captures BDX's situation perfectly. So if you want to update your understanding of BDX or get to know BDX better, this is essential reading. https://beyondspx.com/article/bdx-operational-excellence-and-strategic-focus-drive-value-amidst-headwinds
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 3 at 2:35 PM
$BDX gets a nod in MarketsandMarkets' report forecasting the single-use surgical instrument market to hit $7.8B by 2030. While BD's leadership position is clear, their 34x P/E and margin compression raise questions. Bullish on the sector, cautious on BDX's ability to capitalize without addressing debt and operational inefficiencies. https://www.prnewswire.com/news-releases/7-80-billion-by-2030-why-single-use-surgical-instruments-are-reshaping-global-surgery--marketsandmarkets-302497497.html
0 · Reply
ENFPinvestor
ENFPinvestor Jul. 3 at 1:57 PM
$QNCCF Don’t forget, for this microcap, besides having collaboration with Medical Device Giant Becton Dickenson $BDX they also have collaboration with $TSM Taiwan Semiconductor https://www.stocktitan.net/news/QNCCF/quantum-e-motion-finalizes-qrng-hybrid-chip-design-commences-6dzzw72bu1em.html
0 · Reply
JarvisFlow
JarvisFlow Jul. 2 at 2:42 PM
Citigroup has adjusted their stance on Becton Dickinson ( $BDX ), setting the rating to Buy with a target price of 270 → 217.
0 · Reply
11thestate
11thestate Jul. 1 at 8:26 PM
$BDX agreed to an $85M settlement with investors over claims it misled them about safety issues with its Alaris infusion pumps. Who’s eligible? Anyone who bought and held $BDX stock between November 5, 2019 and February 5, 2020. Do I need to sell to qualify? No — you're eligible if you bought during that period, regardless of whether you sold. How much is the payout? Estimated at $2.14 per share — but typically only 25% of eligible investors file, so it could go up to $8.56 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/bdx-shareholder-settlement
0 · Reply
ENFPinvestor
ENFPinvestor Jun. 30 at 6:22 PM
$QNCCF People don’t realize how big the Greybox partnership is and Quantum eMotion CEO joining as board of director. Greybox has collaborations with Becton Dickenson $BDX (Medical Device Giant), Boehringer Ingelheim (World’s largest privately own Pharmaceutical - German Industry Giant), Medteq, etc. to name a few. It’s going to go mainstream and this is early in the pricing. 🔥🔥🔥
2 · Reply
rcarigl23
rcarigl23 Jun. 24 at 8:44 PM
$NSPR a big player could buy this for pennies $ANGO $BSX $MDT $BDX
0 · Reply
JackDarwin
JackDarwin Jun. 24 at 12:06 PM
$BDX Bullish Engulfing Candlestick Pattern Formed
0 · Reply
11thestate
11thestate Jun. 23 at 8:21 PM
$BDX investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #BectonDickinson #BDX https://11th.com/cases/bdx-shareholder-settlement
0 · Reply